metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Surgical site infection in hepatobiliary surgery patients and its relationship w...
Información de la revista
Vol. 98. Núm. 8.
Páginas 456-464 (octubre 2020)
Visitas
1302
Vol. 98. Núm. 8.
Páginas 456-464 (octubre 2020)
Original Article
Acceso a texto completo
Surgical site infection in hepatobiliary surgery patients and its relationship with serum vitamin D concentration
Infección del sitio quirúrgico en cirugía hepatobiliopancreática y su relación con la concentración sérica de vitamina D
Visitas
1302
Estefania Lavianoa,
Autor para correspondencia
estefania.laviano@gmail.com

Corresponding author.
, María Sancheza, María Teresa González-Nicolása, María Pilar Palacianb, Javier Lópezc, Yolanda Gilaberted, Pilar Calmarzae, Antonio Rezustab, Alejandro Serrabloa
a Servicio de Cirugía General y Digestiva, Hospital Miguel Servet, Zaragoza, Spain
b Servicio de Microbiología, Hospital Miguel Servet, Zaragoza, Spain
c Medicina Familiar y Comunitaria, Sector II, Zaragoza, Spain
d Servicio de Dermatología, Hospital Miguel Servet, Zaragoza, Spain
e Servicio de Bioquímica, Hospital Miguel Servet, Zaragoza, Spain
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (4)
Mostrar másMostrar menos
Tablas (3)
Table 1. Patient characteristics grouped by the presence of surgical site infection. The percentages that are shown in each category have been calculated in relation to infection.
Table 2. Surgical site infections data and agents by diagnostic group and totals.
Table 3. Univariate analysis of the surgical site infection regarding the reference variable.
Mostrar másMostrar menos
Abstract
Introduction

While several studies have examined the correlation between vitamin D concentrations and post-surgical nosocomial infections, this relationship has yet to be characterized in hepatobiliary surgery patients. We investigated the relationship between serum vitamin D concentration and the incidence of surgical site infection (SSI) in patients in our hepatobiliary surgery unit.

Methods

Participants in this observational study were 321 successive patients who underwent the following types of interventions in the hepatobiliary surgery unit of our center over a 1-year period: cholecystectomy, pancreaticoduodenectomy, total pancreatectomy, segmentectomy, hepatectomy, hepaticojejunostomy and exploratory laparotomy. Serum vitamin D levels were measured upon admission and patients were followed up for 1 month. Mean group values were compared using a Student's T-test or Chi-squared test. Statistical analyses were performed using the Student's T-test, the Chi-squared test, or logistic regression models.

Results

Serum concentrations >33.5 nmol/l reduced the risk of SSI by 50%. Out of the 321 patients analyzed, 25.8% developed SSI, mainly due to organ-cavity infections (incidence, 24.3%). Serum concentrations of over 33.5 nmol/l reduced the risk of SSI by 50%.

Conclusions

High serum levels of vitamin D are a protective factor against SSI (OR, 0.99). Our results suggest a direct relationship between serum vitamin D concentrations and SSI, underscoring the need for prospective studies to assess the potential benefits of vitamin D in SSI prevention.

Keywords:
Nosocomial infection
Hepatobiliary surgery
Pancreatic surgery
Surgical site infection
Vitamin D
Resumen
Introducción

La relación entre las infecciones nosocomiales en pacientes quirúrgicos y la vitamina D ha sido estudiada por algunos autores. Sin embargo, hasta la fecha no existe ningún estudio realizado sobre pacientes de cirugía hepatobiliar. El objetivo de nuestro trabajo es estudiar la infección del sitio quirúrgico (ISQ) en la unidad de cirugía hepatobiliar, y valorar su relación con la concentración sérica de vitamina D.

Métodos

Se llevó a cabo un estudio analítico observacional de pacientes sucesivos intervenidos en la unidad de cirugía hepatobiliar de nuestro centro durante un año. Se incluyeron las intervenciones relativas a enfermedad biliar, pancreática y hepática. Se determinaron los niveles de vitamina D al ingreso, así como las ISQ de tipo superficial, profunda y Organ/space diagnosticadas durante el estudio. El seguimiento del paciente se realizó durante al menos un mes tras la cirugía, dependiendo de la enfermedad. La estadística se realizó mediante el programa estadístico R v.3.1.3.

Resultados

La muestra quedó constituida por 321 pacientes, de los cuales el 25,8% presentó ISQ a expensas fundamentalmente de las infecciones Organ/spaces que presentaron una incidencia del 24,3%. Concentraciones séricas superiores a 33,5 nmol/l demostraron reducir en un 50% el riesgo de ISQ.

Conclusiones

Las concentraciones elevadas de vitamina D en sangre demostraron ser un factor protector frente a las ISQ (OR: 0,99). Nuestros resultados sugieren una relación directa entre la concentración sérica de vitamina D y la ISQ, justificando la realización de nuevos estudios prospectivos.

Palabras clave:
Cirugía hepatobiliopancreática
Infección nosocomial
Infección del sitio quirúrgico
Vitamina D
Texto completo
Introduction

Hepatobiliary surgery is a highly complex type of surgery from both a technical and anesthetic standpoint. Morbidity rates after liver surgery range from 17% in benign disease to 27% in malignant disease, with mortality rates close to 5%.1

As for pancreatic resections, overall morbidity rates range between 50% and 60% (59% for pancreatic head resection, 35% for distal resection and 46.7% for total pancreatectomy), depending on the series. The most frequent complications are collections (15.4%) and intra-abdominal abscesses (13.7%). In these procedures, overall mortality is around 3%.2,3

In 2018, Takahashi et al. published a study analyzing the risk factors for surgical site infection (SSI)4 after liver and pancreatic surgery in 735 patients, obtaining a total SSI rate of 17.8%. The interventions with the highest incidence of SSI were hepatectomies with bile duct resection (39.1%), pancreaticoduodenectomies (28.8%) and distal pancreatectomies (29.8%).5 A higher prevalence of the organ/space type was registered, with rates ranging from 25.1% in major hepatectomies to 39.1% in the case of pancreaticoduodenectomies.6

As for cholecystectomy, SSI rates are around 7% in open surgery and barely 1% in elective laparoscopic surgery.5,7

Currently, initiatives like Enhanced Recovery After Surgery (ERAS) seek to improve patients’ preoperative conditions and to improve recovery with the multidisciplinary application of a series of surgical and anesthetic measures.1

Vitamin D has been studied by certain authors for the prevention of nosocomial infections due to its influence on immune system function, since its receptors are expressed by macrophages, B and T lymphocytes, and neutrophils. It is also involved in the synthesis of antimicrobial peptides responsible for innate immunity.8–12

In the case of SSI in particular, publications like the Abdehgah AG et al. study have documented that preoperative vitamin D levels have a significant influence on SSI rates and are considered a protective factor.12

However, no study has addressed its influence on SSI in hepatobiliary surgery in particular. Therefore, the objective of our study is to study SSI in the hepatobiliary surgery unit of our hospital and assess its relationship with preoperative serum vitamin D concentrations.

Methods

A prospective, analytical, observational study was carried out with consecutive patients treated by the hepatobiliary surgery unit of a tertiary hospital during the period of one year. Approval was obtained for the study from the Aragón Clinical Research Ethics Committee (CEICA), and patients gave their informed consent.

Patients who were admitted to the unit for either urgent or scheduled procedures, with hospital stays longer than 48 h, were included in the study. The surgeries analyzed included: cholecystectomy, segmentectomy, minor hepatectomy (<3 segments), major hepatectomy (> 3 segments), distal pancreatectomy, pancreaticoduodenectomy, total pancreatectomy, exploratory laparotomy, and hepaticojejunostomy.

Serum concentrations of vitamin D were determined in all patients both upon admission and afterwards. Superficial, deep and organ/space SSI diagnosed during the study were monitored, both during hospitalization and at the postoperative follow-up office visits one month after surgery and in some cases until June 2019 if the patients had more than one follow-up appointment.

The following data were collected for all patients included in the study: comorbidities, ASA13 and Charlson14 indices, diagnostic data, treatment, NNIS index,4,6 procedural data, results (Clavien-Dindo scale),15 readmissions, reoperations, ICU admission and stay, total hospital stay, mortality, infection and serum concentrations of vitamin D. The diagnosis of infection was made using CDC criteria.16

Vitamin D determinations were performed in the clinical biochemistry laboratory at our hospital with an automated immunoassay using Alinity i 25-OH-vitamin D (Abbot, USA).17,18

Following the guidelines of the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM), vitamin D deficiency was defined as a serum concentration between 20−30 ng/ml (50−75 nmol/L), and deficiency was a level less than 20 ng/ml (< 50 nmol/L). Therefore, serum concentrations between 30 and 75 nmol/L were considered normal.19–21

Statistical analysis

With the data obtained, a database was prepared that was subsequently analyzed using R statistical software, version 3.1.3.

After verifying that they followed a normal distribution with the Shapiro-Wilk test, the quantitative variables were expressed with means and standard deviation. The qualitative variables were expressed through the distribution of frequencies in their categories.

Comparisons between means were made using Student’s t test (continuous variables) or the chi-square test with a correction for continuity (categorical variables). Odds ratios (OR) were calculated from logistic regression models, with the dependent variable (y) being the occurrence/absence of nosocomial infection, and the independent variable(s) were those that were considered of interest. The Wald test was used to calculate the significance of each coefficient of the model. P values less than .05 were considered statistically significant.

When the group variable had 3 categories, comparisons between means were made by analysis of variance (ANOVA) for continuous variables. The bivariate comparisons (post-hoc) were carried out with the Tukey method for parametric variables or the Benjamini-Hochberg method if the explanatory variable did not have a normal distribution.

For the multivariate analysis of the sample, we decided to divide it into tertiles in order to obtain more balanced groups since its size did not allow for conclusions to be drawn with the divisions of the SEIOMM.

ROC curves were used to determine the sensitivity and specificity of plasma vitamin D concentrations as a predictor of SSI. We chose the cut-off point for vitamin D concentration that maximized specificity and sensitivity.

Results

The sample consisted of 321 patients who fulfilled the inclusion criteria of the study, from whom 301 vitamin D samples were obtained that were suitable for analysis. Twenty samples did not meet the conditions required by the analyzer (4 patients from the liver group, 15 from the gallbladder group and 1 from the pancreas group; none of them infected).

Out of the 321 patients, 178 (55.5%) were men and 143 (44.5%) were women, with a mean age of 65 ± 13 years. Their comorbidities, ASA and Charlson scores are shown in Table 1.

Table 1.

Patient characteristics grouped by the presence of surgical site infection. The percentages that are shown in each category have been calculated in relation to infection.

  Cases, N%
Variables  Surgical site infection
  TOTALN = 321  NegativeN = 238  PositiveN = 83  P 
Demographics         
Sex:         
Men  178 (55.5%)  121 (50.8%)  57 (69%)  0.007 
Women  143 (44.5%)  117 (49.2%)  26 (31%)   
Age (yrs) Me ± SD  65 ± 13.1  64 ± 14  67.6 ± 9.60  0.011 
Comorbidities         
Diabetes  63 (20%)  49 (21%)  14 (17%)  0.566 
COPD  27 (8%)  12 (5.04%)  15 (18%)  0.001 
Cardiopathy  55 (17%)  35 (15%)  20 (24%)  0.074 
Obesity  85 (27%)  63 (27%)  22 (27%)  1.000 
Protein malnutrition  117 (37%)  70 (30%)  47 (57%)  <0.001 
Cancer  180 (56%)  123 (52%)  57 (69%)  0.011 
Hospitalization last 18 months  224 (69.8%)  155 (65.1%)  69 (83%)  0.003 
ASA category:        0.001 
48 (15%)  41 (17%)  7 (8%)   
161 (50.2%)  128 (53.8%)  33 (40%)   
3−4  112 (34.9%)  69 (29%)  43 (52%)   
Charlson Index:        0.064 
23 (7%)  20 (8%)  3 (4%)   
22 (7%)  19 (8%)  3 (4%)   
16 (5%)  15 (6%)  1 (1%)   
37 (12%)  28 (12%)  9 (11%)   
+4  222 (69.4%)  155 (65.4%)  67 (81%)   
Vitamin D         
Serum concentrations of 25OHD Me ± SD  38.3 ± 24.6  40.2 ± 26.2  33.2 ± 19.0  0.012 
Vitamin D categories:        0.471 
<50 nmol/L  229 (76.1%)  162 (74.3%)  67 (81%)   
50−75 nmol/L  51 (17%)  39 (18%)  12 (15%)   
>75 nmol/L  21 (7%)  17 (8%)  4 (5%)   
Vitamin D tertiles        0.074 
[8.8,25.5]  102 (33..9%)  67 (31%)  35 (42%)   
(25.5,43.3]  99 (33%)  71 (33%)  28 (34%)   
(43.3,233]  100 (33.2%)  80 (37%)  20 (24%)   
Diagnosis         
Diagnosis:        <0.001 
Liver metastasis  81 (25%)  67 (28%)  14 (17%)   
Hepatic cysts  21 (7%)  13 (5%)  8 (10%)   
Liver carcinoma  16 (5%)  15 (6%)  1 (1%)   
Cholangiocarcinoma  18 (6%)  8 (3%)  10 (12%)   
Cholecystitis  28 (9%)  15 (6.%)  13 (16%)   
Cancer, head of pancreas  45 (14%)  19 (8%)  26 (31%)   
Cancer, body-tail of pancreas  13 (4%)  8 (3%)  5 (6%)   
Cholelithiasis  99 (31%)  93 (39%)  6 (7%)   
Treatment         
Type of procedure:        <0.001 
Segmentectomy and minor hepatectomy  77 (24%)  62 (26%)  15 (18%)   
Major hepatectomy  41 (13%)  28 (12%)  13 (16%)   
Pancreaticoduodenectomy Total pancreatectomy  36 (11%)  12 (5%)  24 (29%)   
Distal pancreatectomy  11 (3%)  7 (3%)  4 (5%)   
Cholecystectomy  122 (38.0%)  104 (43.7%)  18 (22%)   
Exploratory laparotomy  28 (9%)  22 (9%)  6 (7%)   
Hepaticojejunostomy  6 (2%)  3 (1%)  3 (4%)   
Procedure         
Type:        0.003 
Urgent  22 (7%)  10 (4%)  12 (15%)   
Scheduled  299 (93%)  228 (96%)  71 (86%)   
Approach:        <0.001 
Open  208 (65%)  137 (58%)  71 (86%)   
Laparoscopy  113 (35%)  101 (42%)  12 (15%)   
Duration (minutes) Me ± SD  199 ± 94.3  175 ± 77.4  265 ± 106  <0.001 
NNIS index:        <0.001 
50 (16%)  48 (20%)  2 (2%)   
98 (31%)  86 (36%)  12 (15%)   
119 (37.1%)  81 (34%)  38 (46%)   
54 (17%)  23 (10%)  31 (37%)   
Transfusions  53 (17%)  24 (10%)  29 (35%)  <0.001 
Vasopressors  38 (12%)  16 (7%)  22 (27%)  <0.001 
Drainage  204 (65.2%)  126 (55%)  78 (94%)  <0.001 
Preoperative biliary prosthesis  31 (10%)  9 (4%)  22 (27%)  <0.001 
Hospitalization and results         
ICU stay  129 (40%)  71 (30%)  58 (70%)  <0.001 
Days of ICU stay  2.09 ± 5.30  1.23 ± 3.86  4.56 ± 7.67  <0.001 
Readmission  32 (10.0%)  10 (4%)  22 (27%)  <0.001 
Reoperation  32 (10.0%)  7 (3%)  25 (30%)  <0.001 
Clavien Dindo:        <0.001 
136 (42.4%)  136 (57.1%)  0 (0.00%)   
29 (9%)  29 (12.2%)  0 (0.00%)   
52 (16%)  48 (20%)  4 (5%)   
73 (23%)  16 (7%)  57 (69%)   
19 (6%)  6 (3%)  13 (16%)   
12 (4%)  3 (1%)  9 (11%)   
Total stay (days)  10.4 ± 11.3  7.34 ± 8.93  19.0 ± 13.0  <0.001 
Mortality  13 (4%)  2 (1%)  11 (13%)  <0.001 

SSI: surgical site infection; Me: median; SD: Standard deviation; COPD: Chronic obstructive pulmonary disease; NNIS: National Nosocomial Infection Surveillance; ICU: Intensive care unit.

Note 1: Exploratory laparotomies were done in patients who were candidates for the procedure, but who were not candidates for surgery at the time of the operation due to progression of the disease.

Note 2: Four patients were excluded with diagnosis of liver metastases, one patient with cancer of the head of the pancreas and 15 patients with cholelithiasis because their samples were not viable for chromatographic analysis of vitamin D, with no presentations of SSI.

The mean serum concentration of vitamin D, assessed from the 301 viable samples, was 38.3 ± 24.6 nmol/L. More than 76.6% of patients presented <50 nmol/L of vitamin D, which were levels compatible with vitamin D deficiency, and 33.9% were within the lowest tertile (Table 1).

The overall SSI rate was 25.8%, and the interventions with the highest number of registered infections were pancreaticoduodenectomy and total pancreatectomy (29%), cholecystectomy (22%), segmentectomy and minor hepatectomy (<3 segments) (18 %).

SSI were shown to be significantly more prevalent in males (P = .007), patients with protein malnutrition (P < .001), neoplasms (P = .011) and hospitalization in the previous 18 months (P = .003). They also proved to be more frequent in patients with ASA III-IV, who constituted 51.8% of the infected group (P = .001) and with Charlson scores greater than 4 points (80.7%), although this latter case was not significant (P = .064) (Table 1).

The patients with SSI also presented lower concentrations of vitamin D (P = .012), with a mean of 33.2 ± 19 nmol/L. This significance was lost when the sample was divided into tertiles; however, the first tertile was constituted by 42.2% of the patients with SSI (Table 1).

When we analyzed the hospital results, patients with SSI had longer stays in the ICU (4.5 ± 7.7 days vs 1.2 ± 3.8 days) and higher rates of readmission, reoperation and mortality (P < .001) (Table 1).

Regarding the type of SSI by diagnostic group, organ/space infection was the most frequent in all categories. The most frequently detected microorganisms were Escherichia coli and the ‘other gram-negative’ and ‘other gram-positive’ agents (Table 2).

Table 2.

Surgical site infections data and agents by diagnostic group and totals.

LIVER AND BILE DUCTS
Type of SSI  Total: 31 
Superficial  1 (3%) 
Deep  2 (7%) 
Organ/space  28 (90%) 
Isolated pathogens  N of isolations: 36 
Other gram-negative  10 (28%) 
Enterococcus spp.  6 (17%) 
Streptococcus sp.  6 (17%) 
S.aureus and other Staphylococcus  5 (14%) 
Klebsiella spp.  4 (11%) 
E. coli  3 (8%) 
Other gram-positives  2 (6%) 
PANCREAS
Type of SSI  Total: 34 
Deep  1 (3%) 
Organ/space  33 (97%) 
Isolated pathogens  N of isolations: 67 
E. coli  14 (21%) 
Other gram-positives  14 (21%) 
Enterococcus spp.  12 (18%) 
Other gram-negatives  12 (18%) 
Klebsiella spp.  8 (12%) 
Streptococcus spp.  4 (6%) 
S.aureus and other staphylococcus  2 (3%) 
Pseudomonas  1 (2%) 
GALLBLADDER AND DUODENUM
Type of SSI  Total: 20 
Deep  2 (10%) 
Organ/space  17 (90%) 
Isolated pathogens  N isolations: 28 
E. coli  7 (25%) 
Other gram-negatives  7 (25%) 
Other gram-positives  6 (21%) 
Enterococcus spp.  3 (11%) 
Klebsiella spp.  3 (11%) 
Pseudomonas  1 (4%) 
S.aureus and other Staphylococcus  1 (4%) 
TOTAL DATA FOR SSI AND ISOLATED AGENTS
Type of SSI  Total: 85a 
Superficial  3 (4%) 
Deep  3 (4%) 
Organ/space  78 (92%) 
Isolated pathogens  N isolations: 131 
Other gram-negatives  29 (22.1%) 
E. coli  24 (18.3%) 
Other gram-positives  22 (16.8%) 
Enterococcus spp.  21 (16%) 
Klebsiella spp.  15 (11.5%) 
Streptococcus spp.  10 (7.6%) 
S.aureus and other Staphylococcus  8 (6.1%) 
Pseudomonas  2 (1.5%) 

SD: standard deviation; n: number of cases; Me: median; spp.: species.

The category “other gram-negatives” included: Enterobacter spp., Haemophillus spp., Citrobacter spp., etc; and “other gram-positives” included Corynebacterium spp., etc.

a

A total of 85 SSI were recorded; in one of the 84 patients, two types of infection were detected during follow-up (superficial and organ/space).

With regards to comorbidities in the univariate analysis, protein malnutrition (P < .001), neoplasms (P = .007) and hospitalization in the last 18 months (P = .002) were associated with an increased risk of up to 3 times higher (Table 3). In addition, patients who presented ASA III-IV experienced an SSI risk with nearly a four-fold increase (P = .002), as well as patients with high scores on the Charlson index (P < .001) and those that required transfusions and vasopressors with almost 5 times the risk.

Table 3.

Univariate analysis of the surgical site infection regarding the reference variable.

  OR  P 
Demographics     
Sex:
Men  Ref.  Ref. 
Women  0.47 [0.28;0.80]  0.005 
Age (yrs)  1.02 [1.00;1.04]  0.034 
Comorbidities
Diabetes  0.79 [0.40;1.49]  0.473 
Hypertension  1.06 [0.64;1.75]  0.815 
COPD  4.12 [1.83;9.47]  0.001 
Cardiopathy  1.84 [0.98;3.40]  0.059 
Obesity  1.00 [0.56;1.76]  0.986 
Malnutrition  3.10 [1.85;5.23]  <0.001 
SSI  1.79 [0.58;5.06]  0.295 
Neoplasms  2.04 [1.21;3.51]  0.007 
Hospitalization last 18 months  2.61 [1.42;5.11]  0.002 
ASA category:
Ref.  Ref. 
1.49 [0.64;3.93]  0.373 
3−4  3.57 [1.54;9.45]  0.002 
Charlson index:
Ref.  Ref. 
1.05 [0.16;6.80]  0.956 
0.49 [0.02;4.69]  0.560 
2.06 [0.52;10.8]  0.314 
+4  2.76 [0.90;12.5]  0.080 
Vitamin D data
Serum concentration of vitamin D (nmol/L)  0.99 [0.97;1.00]  0.029 
Categories of vitamin D     
<50 nmol/L  Ref.  Ref. 
50−75 nmol/L  0.75 [0.35;1.49]  0.421 
>75 nmol/L  0.59 [0.16;1.67]  0.337 
Supplementation  1.48 [0.49;4.01]  0.462 
Hospital stay and results
Hospitalization in ICU (YES/NO)  5.41 [3.16;9.48]  <0.001 
ICU stay (days)  1.16 [1.07;1.25]  <0.001 
Readmission  8.05 [3.69;18.8]  <0.001 
Reoperation  13.7 [5.91;36.3]  <0.001 
Total stay (Days)  1.11 [1.07;1.14]  <0.001 
Mortality  16.7 [4.28;120]  <0.001 
Treatment
Procedure:
Segmentectomy and minor hepatectomy  Ref.  Ref. 
Major hepatectomy  1.91 [0.79;4.60]  0.150 
Pancreaticoduodenectomy and total pancreatectomy total  8.02 [3.34;20.4]  <0.001 
Distal pancreatectomy  2.36 [0.54;9.18]  0.240 
Cholecystectomy  0.72 [0.33;1.55]  0.390 
Exploratory laparotomy  1.14 [0.36;3.23]  0.815 
Hepaticojejunostomy  4.04 [0.64;25.7]  0.131 
Procedure
Type:
Urgent  Ref.  Ref. 
Scheduled  0.26 [0.11;0.64]  0.003 
Approach:
Open  Ref.  Ref. 
Laparoscopic  0.23 [0.11;0.44]  <0.001 
Duration  1.01 [1.01;1.01]  <0.001 
NNIS index:
Ref.  Ref. 
3.14 [0.80;22.7]  0.109 
10.4 [2.99;71.4]  <0.001 
29.4 [7.89;2.09]  <0.001 
Transfusions  4.58 [2.47;8.58]  <0.001 
Vasopressors  4.83 [2.39;9.95]  <0.001 
Drain tubes  12.4 [5.32;37.0]  <0.001 
Preoperative biliary stent  9.01 [4.04;21.8]  <0.001 
Hospital stay and results
Hospitalization in ICU  5.41 [3.16;9.48]  <0.001 
ICU stay (days)  1.16 [1.07;1.25]  <0.001 
Readmission  8.05 [3.69;18.8]  <0.001 
Reoperation  13.7 [5.91;36.3]  <0.001 
Total stay (days)  1.11 [1.07;1.14]  <0.001 
Mortality  16.7 [4.28;120]  <0.001 

Ref.: reference category; COPD: chronic obstructive pulmonary disease; CKF: chronic kidney failure; ASA: American Society of Anesthesiologists; NNIS: National Nosocomial Infection Surveillance; ICU: intensive care unit.

The biliary stent category includes all patients who had a prosthesis prior to surgery.

Scheduled surgery and the laparoscopic approach showed a significant decrease in the risk of SSI (P = .003 and P < .001). Pancreaticoduodenectomies were the procedure type with the highest increased risk for SSI (P < .001).

High concentrations of vitamin D in the blood constituted a protective factor against SSI, presenting on the other hand a low level of significance (OR: 0.99; [0.97−0.99]).

Regarding the multivariate analysis of the sample by vitamin D tertiles, a significant increase in the OR was observed in patients located in the third tertile (vitamin D > 43.3 nmol/L) compared to the lowest tertile (vitamin D < 25 nmol/L), which resulted in a significant decrease in the risk of SSI when the serum concentration of vitamin D increased (Fig. 1).

Fig. 1.

Multivariate analysis of the risk for surgical site infection, according to tertiles of vitamin D.

(0.08MB).

These differences were also confirmed in the model adjusted for sex, age, Charlson and type of surgery (urgent/scheduled) (Fig. 2).

Fig. 2.

Multivariate analysis of surgical site infection occurrence by tertiles of vitamin D, adjusted for sex, age, Charlson index and type of surgery.

(0.09MB).

Finally, by analyzing the sensitivity and specificity of vitamin D as a predictor for SSI, we found that values greater than or equal to 33.5 nmol/L reduced the risk of developing SSI by 50% (Fig. 3).

Fig. 3.

ROC curve of vitamin D plasma concentrations as a predictor for surgical site infection (SSI): values greater than or equal to 33.5 nmol/L reduce the risk of SSI by 50% with a sensitivity of 65.1% and a specificity of 51.4%.

AUC: area under the curve.

(0.05MB).
Discussion

SSI ranks second among the most prevalent nosocomial infections, and it is the most frequent in surgical patients. Each SSI adds an average of 11 days to hospital stay and an average cost of €4,000.22–24

Our study registered 25.8% SSI, mainly organ/space infections (24.3%). This result is higher than the rates reported by Takahashi et al. and Moreno Elola-Olaso et al., who, in 2012, obtained post-hepatectomy infection rates of 4%-20% and an SSI incidence after liver resection of 2.1%-14.5%. However, the rates registered in our study were lower in terms of superficial and deep SSI, both of which were 1.2%.5,6

In contrast, major hepatectomies recorded results similar to those described above, with an SSI incidence of 31.7%, while pancreaticoduodenectomies had almost 67% SSI.5,6

These results, although high, should be analyzed in the context of our hospital, which is a referral center in our community for complex liver and pancreatic surgery.

As for cholecystectomies, the SSI rate was 1.5%, which is a lower result than other published reports if we take into account that the majority of infected patients underwent emergency and open surgery.5,7

There was also a lower incidence of SSI in the laparoscopic approach compared to open surgery, which is in line with what has been published to date, despite the fact that 65% of the interventions were performed with this approach.4

As for vitamin D, the mean concentration was 38.3 ± 24.6 nmol/L, compatible with deficiency. To date, the only study carried out in serum concentrations of vitamin D in non-cardiac surgery patients is the publication by Turan et al. in 2014, which registered an average of 23.5 ng/ml (also within the range of deficiency9). However, there have been studies in bariatric patients, such as the Quaraishi S.A. et al. study,25 which also obtained serum concentrations <30 ng/mL.

In 2012, Dima et al. published a bibliographic review on the potential effects of vitamin D in reducing nosocomial infections, which confirmed that vitamin D deficiency increased the predisposition towards Staphylococcus aureus infections and was associated with worse wound healing.21,26

According to serum concentrations of vitamin D, other studies have verified that there are differences in the results obtained in patients infected by certain microorganisms, such as Clostridium difficile, S. aureus, MRSA and Pseudomonas aeruginosa. Infected patients present hospital stays that are 4 times longer, at an increased cost of nearly five-fold.26,27

Regarding the microorganisms isolated in SSI, Múñez et al. conducted a study in 2011 in patients with digestive tract procedures, and they observed a predominance of gram-negative bacilli of digestive origin, together with gram-positive streptococci, enterococci and staphylococci. The most frequently isolated microorganisms were: Escherichia coli (28%), Enterococcus spp. (15%), Streptococcus spp. (8%), Pseudomonas aeruginosa (7%) and Staphylococcus aureus (5%).28

In our sample, we also verified a significant percentage of gram-negative infections of digestive origin (22%) and similar isolation rates for Enterococcus spp., Pseudomonas spp. and S. aureus, but fewer isolated E. coli (18%) (Table 2).

To date, no study of this type has been carried out to analyze the relationship between SSI and serum vitamin D concentrations in hepatobiliary surgery. Our study population was found to have levels similar to previous publications,9,25,26,29 confirming that protein malnutrition and prolonged surgical time were the main risk factors.6

We have verified the existence of significant differences in terms of SSI when comparing patients in the lower and upper tertiles, and there was a significant decrease in SSI risk of 50% with concentrations of 33.5 nmol/L or more.

As limitations of our study, it should be noted that we have tried to eliminate the possible confounding factors with statistical adjustment of the multivariate analysis and the study of multiple demographic variables. However, we are aware of other confounding factors that may have gone unnoticed. Furthermore, the sample does not have a sufficient size to draw conclusions by diagnostic group regarding SSI and vitamin D, which is a reason for to future studies with a larger sample size.

The results of our study suggest a correlation between serum vitamin D concentration and surgical SSI in hepatobiliary surgery, which justifies future prospective studies to assess the possible benefits of optimizing vitamin D before surgery and the influence of postoperative supplementation.

Funding

No external funding was received of any kind.

Conflict of interests

The authors have no conflict of interests to declare.

References
[1]
E. Melloul, M. Hübner, M. Scott, C. Snowden, J. Prentis, C.H.C. Dejong, et al.
Guidelines for perioperative care for liver surgery: enhanced recovery after surgery (ERAS) Society Recommendations.
World J Surg., 40 (2016), pp. 2425-2440
[2]
Herrera-Cabezón Francisco Javier, S.ánchez-Acedo Pablo, Zazpe-Ripa Cruz, Tarifa-Castilla Antonio, Lera-Tricas José Miguel.
Quality standards in 480 pancreatic resections: a prospective observational study.
Rev. Esp. Enferm. Dig., 107 (2015), pp. 143-151
[3]
E. Dominguez-Comesaña, F.J. Gonzalez-Rodriguez, J.L. Ulla-Rocha, A. Lede-Fernandez, et al.
Morbimortalidad de la resección pancreática.
Cir Esp., 91 (2013), pp. 651-658
[4]
WHO.
Global Guidelines for the Prevention of Surgical Site Infection.
(2016),
[5]
Y. Takahashi, Y. Takesue, M. Fujiwara, S. Tatsumi, K. Ichiki, J. Fujimoto, et al.
Risk factors for surgical site infection after major hepatobiliary and pancreatic surgery.
J Infect Chemother., 24 (2018), pp. 739-743
[6]
A. Moreno Elola-Olaso, D.L. Davenport, J.C. Hundley, M.F. Daily, R. Gedaly.
Predictors of surgical site infection after liver resection: A multicentre analysis using National Surgical Quality Improvement Program data.
[7]
S. Ely, K.A. Rothenberg, G. Beattie, R.C. Gologorsky, M.R. Huyser, C.K. Chang.
Modern elective laparoscopic cholecystectomy carries extremely low postoperative infection risk.
J Surg Res., 246 (2020), pp. 506-511
[8]
M. Di Rosa, M. Malaguarnera, F. Nicoletti, L. Malaguarnera.
Vitamin D3: A helpful immuno-modulator.
Immunology., 134 (2011), pp. 123-139
[9]
A. Turan, B.D. Hesler, J. You, L. Saager, M. Grady, R. Komatsu, et al.
The association of serum vitamin D concentration with serious complications after noncardiac surgery.
Anesth Analg., 119 (2014), pp. 603-612
[10]
M.F. Holick, T.C. Chen.
Vitamin D deficiency: a worldwide problem with health consequences.
Am J Clin Nutr., 87 (2008),
[11]
M.F. Holick, M. Garabedian.
Vitamin D: photobiology, metabolism, mechanism of actionmand clinical applications. En John Wiley & sons, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 8º Edición.
Wiley and Blackwell, (2006), pp. 129-137
[12]
A.G. Abdehgah, A. Monshizadeh, M.M. Tehrani, S. Afhami, B. Molavi, M. Jafari, et al.
Relationship Between Preoperative 25-Hydroxy Vitamin D and Surgical Site Infection.
J Surg Res., 245 (2020), pp. 338-343
[13]
N.J. Hackett, G.S. De Oliveira, U.K. Jain, J.Y.S. Kim.
ASA class is a reliable independent predictor of medical complications and mortality following surgery.
Int J Surg., 18 (2015), pp. 184-190
[14]
J. Gil-Bona, A. Sabaté, J.M. Miguelena Bovadilla, R. Adroer, et al.
Valor de los índices de Charlson y la escala de riesgo quirúrgico en el análisis de la mortalidad operatoria.
Cir Esp., 88 (2010), pp. 174-179
[15]
D. Dindo, N. Demartines, P.A. Clavien.
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
[16]
CDC.
Procedure associated module.Surgical Site Infection.
(2020),
[17]
G.D. Carter.
25-hydroxyvitamin D: a difficult analyte.
Clin Chem., 58 (2012), pp. 486-488
[18]
N. Binkley, D. Krueger, C.S. Cowgill, L. Plum, E. Lake, K.E. Hansen, et al.
Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization.
J Clin Endocrinol Metab., 89 (2004), pp. 3152-3157
[19]
M.J. Gómez de Tejada, M. Sosa, J. Del Pino, E. Jódar, J.M. Quesada, et al.
Documento de posición sobre las necesidades y niveles óptimos de vitamina D.
Rev Osteoporos y Metab Miner., 3 (2011), pp. 53-68
[20]
C.J. Rosen, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, et al.
IOM committee members respond to endocrine society vitamin D guideline.
J Clin Endocrinol Metab., 97 (2012), pp. 1146-1152
[21]
Y. Gilaberte, R. Sanmartín, C. Aspiroz, A. Hernandez-Martin, D. Benito, et al.
Correlation Between Serum 25-Hydroxyvitamin D and Virulence Genes of Staphylococcus aureus Isolates Colonizing Children with Atopic Dermatitis.
Pediatr Dermatol., 32 (2015), pp. 506-513
[22]
J.E. Varela, S.E. Wilson, N.T. Nguyen.
Laparoscopic surgery significantly reduces surgical-site infections compared with open surgery.
Surg Endosc., 24 (2010), pp. 270-276
[23]
M.J. Seamon, J. Wobb, J.P. Gaughan, H. Kulp, I. Kamel, D.T. Dempsey.
The effects of intraoperative hypothermia on surgical site infection: an analysis of 524 trauma laparotomies.
Ann Surg., 255 (2012), pp. 789-795
[24]
M.L. Schweizer, J.J. Cullen, E.N. Perencevich, M.S. Vaughan Sarrazin.
Costs Associated With Surgical Site Infections in Veterans Affairs Hospitals.
JAMA Surg., 149 (2014), pp. 575-581
[25]
D.A. Youssef, T. Ranasinghe, W.B. Grant, A.N. Peiris.
Vitamin D’s potential to reduce the risk of hospital-acquired infections.
Dermatoendocrinol., 4 (2012), pp. 167-175
[26]
D.A. Youssef, B. Bailey, A. El Abbassi, R. Copeland, L. Adebonojo, et al.
Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency.
Epidemiol Infect., 138 (2010), pp. 1322-1327
[27]
E. Múñez, A. Ramos, Espejo T.Á de, J. Vaqué, J. Sánchez-Payá, et al.
Microbiología de las infecciones del sitio quirúrgico en pacientes intervenidos del tracto digestivo.
Cirugía Española., 89 (2011), pp. 606-612
[28]
S.A. Quraishi, E.A. Bittner, L. Blum, M.M. Hutter, C.A. Camargo.
Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following roux-en-Y gastric bypass surgery.
JAMA Surg., 149 (2014), pp. 112-118
[29]
K. Tomita, N. Chiba, S. Ochiai, K. Yokozuka, T. Gunji, K. Hikita, et al.
Superficial Surgical Site Infection in Hepatobiliary-Pancreatic Surgery: Subcuticular Suture Versus Skin Staples.
J Gastrointest Surg., 22 (2018), pp. 1385-1393

Please cite this article as: Laviano E, Sanchez M, González-Nicolás MT, Palacian MP, López J, et al. Infección del sitio quirúrgico en cirugía hepatobiliopancreática y su relación con la concentración sérica de vitamina D. Cir Esp. 2020;98:456–464.

Copyright © 2020. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos